From Journal
of Medical Case Reports
Fulminant Leptospirosis (Weil's Disease)
in an Urban Setting as an Overlooked Cause of Multiorgan Failure: A Case Report
Elias Maroun; Anurag Kushawaha; Elie El-Charabaty; Neville
Mobarakai; Suzanne El-Sayegh
Posted: 03/06/2011; J Med Case Reports. 2011;5(1) © 2011
BioMed Central, Ltd.
Abstract Introduction: |
Discussion
Leptospirosis is a zoonosis of worldwide distribution
caused by infection with L. interrogans, a
pathogenic spirochete. The organism infects a variety of animals, especially
rodents and animals associated with farming. Humans represent only incidental
infection usually through work-related contact through skin or mucous
membranes, typically after exposure to water or soil contaminated with urine
from an infected animal or via drinking of or bathing in contaminated water.
The main occupational groups at risk are farm workers, field agricultural
workers, plumbers, sewer workers, sanitation workers and military troops.
Leptospira are spiral-shaped, thin, motile organisms
with flagella. The most common serovars are icterohaemorrhagiae,
which are usually found in rats (Rattus norvegicus).
Urinary shedding of organisms from infected animals is the most significant
source of Leptospira spp. because the
spirochetes can persist for long periods of time in the renal tubules.
The natural course of leptospirosis comprises of two
distinct clinical phases: septicemic and immune. Humans typically become ill
seven to 12 days after exposure to leptospires. The first stage is called the
septicemic phase (leptospiremic phase) because the bacteria may be isolated
from blood cultures and cerebrospinal fluid (CSF). This phase is characterized
by a nonspecific flulike illness with sudden onset of high fever, headache,
myalgias (classically involving the paraspinal, calf and abdominal muscles)[1] and
conjunctival suffusion. Conjunctival suffusion (reddening of the eye surface)
is a characteristic physical finding in leptospirosis, and its presence in a
patient with a nonspecific febrile illness should raise suspicion for
diagnosis.
The second stage is called the immune phase
(leptospiruric phase) when circulating antibodies can be detected and the
bacteria can be isolated from the urine. This stage occurs as a result of the
body's immunologic response by producing immunoglobulin M antibodies and can
last longer than one month. During this stage, specific organ damage can be
observed. Aseptic meningitis is one of the most important clinical syndromes
that can occur in 80% of patients during the immune phase. Renal symptoms, such
as uremia, azotemia, pyuria and hematuria, may occur. Pulmonary manifestations,
although usually benign, can be potentially life threatening and range from
chest pain, cough and dyspnea to pulmonary hemorrhage or acute respiratory
distress syndrome. An increase in liver enzymes (up to five times normal) with
a disproportionately high total bilirubin has been described as a prognostic
indicator in leptospirosis.[2] Varying
degrees of jaundice, pancreatitis, hepatomegaly and myocarditis can also occur.
Weil's disease is the most severe form of
leptospirosis. Patients can present with high fever (>40°C), significant
jaundice, renal failure, hepatic necrosis, pulmonary involvement,
cardiovascular collapse, neurologic changes and hemorrhagic diathesis, with a
variable clinical course. Weil's disease can occur at the end of the first
stage and peaks during the second stage but can occur at any time during acute
leptospirosis as a single, progressive illness.
Acute renal failure is one of the most common
complications of severe leptospirosis. Renal leptospirosis is usually described
as a combination of acute tubular damage and interstitial nephritis.
A particularly serious type of lung involvement called
severe pulmonary hemorrhagic syndrome is considered to be a major cause of
death in patients with Weil's disease in developing countries, with profuse
lung hemorrhage dominating the clinical picture.[3]
Hepatic dysfunction is usually mild and reversible.
Liver dysfunction in severe leptospirosis can be seen as conjugated serum
bilirubin levels may increase to above 80 mg/dL, accompanied by modest
elevations in transaminases, which rarely exceed 200 U/L.[4]
Variable degrees of thrombocytopenia have been
reported with leptospirosis. The pathogenesis of thrombocytopenia and
hemorrhagic diathesis in leptospirosis is not well understood.
Overall, Weil's syndrome has a mortality rate of 5% to
10%. Important causes of death include renal failure, cardiopulmonary failure
and widespread hemorrhage.[5]
The diagnosis of leptospirosis requires a high degree
of clinical suspicion because the disease's numerous manifestations can mimic
other tropical infections or other nonspecific febrile illnesses, as well as
noninfectious diseases such as small vessel vasculitides, systemic lupus
erythematosus or even malignancies. The initial diagnosis of leptospirosis
remains a clinical one, a presumed analysis in the appropriate epidemiologic
and clinical context. Routine laboratory testing is nondiagnostic but may show
elevated erythrocyte sedimentation rate, peripheral leukocytosis, variable
degrees of cytopenias, mildly increased aminotransferases and increased serum
bilirubin and ALP.
Isolation of the organism by culture of clinical
specimens (blood, CSF, urine) during the first seven to 10 days of the illness
is considered the gold standard of diagnosis. However, this method is
difficult, requires longer than 16 weeks because initial growth may be slow and
has a low sensitivity and specificity. The majority of leptospirosis cases are
diagnosed by serologic testing of which MAT is most common
The vast majority of infections with leptospira are
self-limiting, and it remains controversial if antimicrobials produce benefit
in cases of mild leptospirosis without end-organ damage. The current choices of treatment for mild leptospirosis include oral
doxycycline and amoxicillin. Parenteral
high-dose penicillin G has long been considered the treatment of choice of
fulminant leptospirosis. Recent trials have demonstrated that the
broad-spectrum third generation cephalosporins cefotaxime and ceftriaxone are
also acceptable agents for patients with severe leptospirosis.[6,7]
The use of steroids in patients with leptospirosis has
not been well established. In the
current case, the improvement of the patient's renal dysfunction,
thrombocytopenia and hemoptysis may be attributed to the introduction of
steroids. Several case reports have described the beneficial effects of
glucocorticoids in severe leptospirosis with pulmonary hemorrhage,[8]
thrombocytopenia[9]
and renal failure.[10,11]
Public health measures to prevent and reduce
leptospirosis include identification of contaminated water sources, rodent
control, prohibition of swimming in waters where risk of infection is high and
informing persons of the risk involved in recreational water activities.
In the case of our patient, the diagnosis of
leptospirosis was not initially considered because potential risk factors were
not identified at the outset. The majority of cases of leptospirosis occur in
the tropics, with infrequent incidences in temperate regions. Adding another
atypical facet to the patient's presentation, in the United States, the
majority of cases occur in the Southern and Pacific coastal states, with Hawaii
having the most reported cases. Also, our patient presented in the wintertime.
Most cases of leptospirosis occurring in temperate areas occur in the late
summer to early fall.[1]
According to the NYC Board of Health, between 2008 and summer 2009, there were
only three cases of leptospirosis in NYC (including our patient).
沒有留言:
張貼留言